Facebook Icon Print Created with Sketch. Twitter Icon Created with Sketch. Created with Sketch. LinkedIn Icon Green Check Icon Created with Sketch. YouTube Icon Right Arrow Icon Mobile Menu Icon Chevron Right Icon Phone Icon Health Study Area: AutoImmune Disease Health Study Area: Blood Cancer Health Study Area: Cardiovascular Disease Health Study Area: Fibrosis Health Study Area: Gastrointestinal Cancer Health Study Area: Genitourinary Health Study Area: Head and Neck Cancer Health Study Area: Lung Cancer Health Study Area: Melanoma Health Study Area: Women's Cancer For Caregivers For Clinicians Communities FAQs For Parents For Patients Chevron Icon Bookmark Icon Map Icon Share Icon Direction Arrow Icon Direction Arrow Icon Page Icon Location Icon Search Icon External Link Icon Help Icon Error Icon Glossary Email Icon Gender Both Gender Male Gender Female Created with Sketch. Created with Sketch.

Please Log In/Join Now first, and then use this function!

Living With IBD? Consider a clinical trial.

Consider a clinical trial to help find answers that may lead to improved treatment.

Living with Inflammatory Bowel Disease often means planning your life around the restroom

It can be embarrassing and tiring, and you never know when your symptoms will flare. If you are one of the many people living with Inflammatory Bowel Disease, consider a clinical trial, you may be able to give something back to others like you.

It can be embarrassing and tiring, and you never know when your symptoms will flare. If you are one of the many people living with Inflammatory Bowel Disease, consider a clinical trial, you may be able to give something back to others like you.

The information you provide is completely confidential and will only be disclosed with your permission except as required by law.

See if you might qualify

What do the Lattice clinical research studies involve?

Doctors around the world are working hard to try and find new ways to treat IBD (Inflammatory Bowel Disease) and they need help. You see, study participants are at the heart of any study. Without them, clinical research studies simply would not be possible. And without clinical research studies, no new IBD drugs can be developed.

The Lattice studies want to see how safe and effective a study drug is at reducing the symptoms of moderate to severe IBD. We are looking for adults 18-80 years of age with a diagnosis of moderate-to-severe Crohn’s Disease or Ulcerative Colitis.  The Lattice studies are looking for approximately 360 participants. 

How long is the Lattice Study?

How long is the Lattice Study?

The Lattice Study lasts about 60 weeks (or about 14 months). If you are eligible and are referred to the study clinic, the study team can provide you with more information about the study visits that are required.

You won’t be asked for any personal information until after you have completed the questionnaire and decided to proceed. Your information will only be used for the purposes of this study.

Supporting your loved one

  • About the Lattice Study

    Who can participate in a clinical trial?

    Only participants who meet all required eligibility criteria for a clinical trial may take part. The study team at the clinic you select will review your medical history and current medical status against the eligibility criteria. They will determine if you are eligible to participate in the trial. You may also be asked to provide information from your medical records to help the study team determine if you could be eligible.

    Why is this clinical trial being conducted?

    The purpose of the Lattice Study is to evaluate how well the oral investigational drug works and how safe it is in patients with IBD.

    What happens if I pre-qualify?

    If you pre-qualify and decide to participate, you may be referred to the nearest study clinic for a screening visit. At the study clinic, you may meet with the study team to go over the Informed Consent Form, review additional participation criteria, and take part in an initial evaluation/test to determine your study eligibility.

    How do I decide if this clinical trial is right for me?

    Before you agree to participate, the study team will review all aspects of the clinical trial with you, including required study assessments. You will be given a document called an Informed Consent Form that provides, in writing, the clinical study's purpose, assessments, procedures, benefits, risks, and precautions. You will have the opportunity to ask questions and are encouraged to speak with your own physician to decide if taking part is right for you.

    Who can I contact with more questions?

    The study doctor and research nurse can provide more information and answers to your questions.

    Will I be paid for taking part/reimbursed for travel?

    You will not be paid for taking part in the clinical trial. You may be responsible for other costs (for example, tests you would receive as part of regular care for your condition), some of which may be covered by your insurance. The study team can inform you about reimbursement for reasonable travel expenses incurred to attend study visits if you are eligible and are referred to a clinic.
  • About the Investigational Drug

    Why is the investigational drug being studied?

    The oral investigational drug is being evaluated to see how well it works and how safe it is for patients with Crohn’s disease. You may be able to continue your current Crohn’s disease medication along with the oral investigational drug.

    What is the name of the investigational drug?

    Because this drug is still being evaluated and has not been approved by a health authority, it does not have a name. Instead, it is referred to as BMS-986165.

    What is a placebo?

    A placebo is an inactive drug sometimes given to a control group. Placebos are used so investigators can compare it to the experimental drug being studied. In cancer trials, patients are provided with at least the standard of care and a placebo is not used.

    What are the chances of receiving the placebo

    If you participate in the Lattice Study, during the initial study phase you will have a 3 in 4 chance of receiving the investigational drug and a 1 in 4 chance of receiving the placebo.

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -
Call 855-907-3286 or email clinical.trials@bms.com